during intake of four different hormonal contraceptives : ovosiston ( mestranol 0,08 mg , chlormadinone acetate 2 mg ) , non ovlon ( ethinylestradiol 0,05 mg , norethindrone acetate 1 mg ) , sequenz-ovosiston and deposiston ( 4th , 11th and 18th cycle day 1 mg ethinylestradiolsulfonate , 25th cycle day 10 mg norethindrone acetate ) an increase of fibrinolytic split products in contrast to low values of the normal menstrual cycle is to be seen .
C0025506
mestranol
C0015011
ethinylestradiol